| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Clinical Order | $101.7M | $105.2M | $109.1M | $181.5M | $221.7M | $235.4M | $245.9M | $239.3M |
| Insights Product | $40.7M | $50.1M | $64.7M | $49.5M | $57.2M | $69M | $82M | $71.3M |
| Genomics Product | $112.3M | $116.4M | — | $12.3M | $241.8M | $252.9M | — | $21.8M |
| Trials Product | $10.5M | $10.1M | $10.6M | $9.7M | $9.8M | $9.2M | $9.8M | $9.9M |
| Next Product | — | — | — | — | — | — | — | $5.7M |
| Total | $165.97M | $180.93M | $200.68M | $255.74M | $314.64M | $334.21M | $367.21M | $348.12M |
AI Applications is derived from annual filings.